MedPath

Influence of Chocolate With Plant Additives on Episodic Memory in Healthy Subjects Experiencing Test Anxiety

Not Applicable
Completed
Conditions
Test Anxiety
Interventions
Dietary Supplement: High Epicatechin/ Melissa
Other: Low Epicatechin/ Oat bran
Registration Number
NCT03382067
Lead Sponsor
Prof. Dominique de Quervain, MD
Brief Summary

Randomized, blind parallel group design. Single intake of 55 g high Epicatechin /Melissa dark chocolate containing 160 mg Epicatechin per 55 g serving or single intake of 55 g low Epicatechin/ oat bran white chocolate containing \< 0,00045 mg Epicatechin per 55 g serving.

A Total of 128 participants, 64 in each group, approx. equal number of male and female. There will be replacement of Drop-Outs until data from 128 participants are completed.

The primary endpoints will be performance in a pictorial memory task and a verbal memory task .

The secondary endpoints will be performance in a working memory test, Saliva cortisol, Visual analog scales assessing, anxiety, confidence, interference, solicitude, and excitement.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
128
Inclusion Criteria
  • Healthy by history
  • normotensive (BP between 90/60 mmHg and 140/90 mmHg)
  • BMI between 18 and < 30 kg/m2
  • male or female
  • aged between 18 and 30 years
  • native or fluent German-speaking
  • Prüfungsangstfragebogen (PAF) total or subscale interference score T value > 60
Exclusion Criteria
  • Known hypersensitivity or allergy to cocoa, Melissa, oat, vanillin, milk, soja, nuts
  • gluten intolerance
  • lactose intolerance
  • acute or chronic psychiatric disorder including drug or alcohol abuse
  • women who are pregnant or breast feeding
  • any clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease etc., infections)
  • known or suspected non-compliance
  • smoking (> 5 cigarettes per day)
  • participation in one of our previous studies using the same memory tests in the past 2 years
  • participation in a study with investigational drug within the 30 days preceding and during the present study
  • long-term medication within last 3 months (oral contraceptives are disregarded)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High Epicatechin/ MelissaHigh Epicatechin/ MelissaSingle consumption of a 55g bar of dark chocolate containing: 42.8g Acticoa ® chocolate + 7.2g caster sugar + 5g Melissa containing 374 mg (-)-Epicatechin/100g chocolate and 2,69% of rosmarinic acid in Melissa leaves
Low Epicatechin/ Oat branLow Epicatechin/ Oat branSingle consumption of a 55g bar of white chocolate containing: 50g Lindor ® chocolate + 5g oat bran containing \< 0,0009 mg (-)-Epicatechin/100g
Primary Outcome Measures
NameTimeMethod
Verbal memory task25 minutes and 24 h after presentation

Six series of five semantically unrelated nouns will be presented.Total score is calculated by summing the number of correctly recalled words

Pictorial memory task25 minutes and 24 h after presentation

Participants will be presented with 24 neutral, 24 positive and 24 negative photographs in a random order. Scores will be calculated by summing the correctly remembered photographs per valence.

Secondary Outcome Measures
NameTimeMethod
Saliva cortisol level1 day after word/picture presentation Start /middle and end of day. Baseline cortisol 1-14 days later.

Samples are collected at different timepoints during the day in order to measure stress related cortisol activity. Participants have to chew a cotton sponge for 2-3 minutes, which then are contained in a special device

Visual Analogue Scale VAS confidence1 day after word/picture presentation

will be assessed between each task by the participant using a visual analogue scale. Respondents specify their level of agreement to the statement by indicating a position along a continuous line (10 cm).

Visual Analogue Scale VAS solicitude1 day after word/picture presentation

will be assessed between each task by the participant using a visual analogue scale. Respondents specify their level of agreement to the statement by indicating a position along a continuous line (10 cm).

Visual Analogue Scale VAS test anxiety1 day after word/picture presentation

will be assessed between each task by the participant using a visual analogue scale. Respondents specify their level of agreement to the statement by indicating a position along a continuous line (10 cm).

Visual Analogue Scale VAS interference1 day after word/picture presentation

will be assessed between each task by the participant using a visual analogue scale. Respondents specify their level of agreement to the statement by indicating a position along a continuous line (10 cm).

Working memory1 day after word/picture presentation

Participants will have to calculate as many arithmetical means of seven one-digit numbers possible within two minutes by mental calculation.

Visual Analogue Scale VAS excitement1 day after word/picture presentation

will be assessed between each task by the participant using a visual analogue scale. Respondents specify their level of agreement to the statement by indicating a position along a continuous line (10 cm).

Trial Locations

Locations (1)

University of Basel, Division of Cognitive Neuroscience

🇨🇭

Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath